WealthCollab’s Dr. Reddy's Laboratories RDY Stock Holding History

WealthCollab’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.8K	Sell	3,987 -180	-4%	-$2.43K	0.02%	216
2026 Q1	$57.7K	Sell	4,167 -374	-8%	-$5.21K	0.02%	193
2025 Q4	$63.8K	Buy	4,541 +554	+14%	+$7.77K	0.03%	197
2025 Q3	$55.7K	Hold	3,987	–	–	0.03%	185
2025 Q2	$59.9K	Buy	3,987 +417	+12%	+$5.96K	0.03%	165
2025 Q1	$47.1K	Sell	3,570 -1,935	-35%	-$26.7K	0.03%	170
2024 Q4	$86.9K	Buy	5,505 +860	+19%	+$12.9K	0.06%	106
2024 Q3	$73.8K	Hold	4,645	–	–	0.05%	130
2024 Q2	$70.8K	Buy	4,645 +190	+4%	+$2.72K	0.05%	124
2024 Q1	$65.4K	Hold	4,455	–	–	0.05%	132
2023 Q4	$62K	Buy	+4,455	New	+$59.6K	0.05%	127

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

WealthCollab's RDY Position: Q2 2026 in Review

WealthCollab reduced its Dr. Reddy's Laboratories (RDY) stake by 4.3% in Q2 2026, selling an estimated $2.43K and leaving 3,987 shares worth $57.8K. The position accounts for 0.02% of the portfolio, ranked #216.

WealthCollab first reported a position in RDY in Q4 2023 and has held it in 11 quarters since. The position peaked at $86.9K in Q4 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

WealthCollab held 3,987 shares of Dr. Reddy's Laboratories worth $57.8K as of Q2 2026.
WealthCollab sold 180 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $2.43K.
Dr. Reddy's Laboratories made up 0.02% of WealthCollab's portfolio in Q2 2026, its #216 holding.
WealthCollab first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 11 quarters since.
WealthCollab's Dr. Reddy's Laboratories position peaked at $86.9K in Q4 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.